Clinical Trial Detail

NCT ID NCT02073838
Title Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarit Assouline
Indications

acute myeloid leukemia

Therapies

Decitabine

Ribavirin + Vismodegib

Age Groups: adult

No variant requirements are available.